AeroLeads people directory · profile
Adam Friedman, Ph.D. Email & Phone Number
Director of Research and Development
at
Atom Bioworks
1 work email found
@atombioworks.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Director of Research and Development
Location
Chapel Hill, North Carolina, United States
Company size
Who is Adam Friedman, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Adam Friedman, Ph.D. is listed as Director of Research and Development at Atom Bioworks, a company with 8 employees, based in Chapel Hill, North Carolina, United States. AeroLeads shows a work email signal at atombioworks.com and a matched LinkedIn profile for Adam Friedman, Ph.D..
Adam Friedman, Ph.D. previously worked as Director of Research & Development at Atom Bioworks and Strategic Advisor and Consultant, i.e., sabbatical position at Atom Bioworks. Adam Friedman, Ph.D. holds Doctor Of Philosophy (Ph.D.), Pharmaceutical Sciences from University Of North Carolina At Chapel Hill.
Company email context
Email format at Atom Bioworks
This section adds company-level context without repeating Adam Friedman, Ph.D.'s masked contact details.
*@atombioworks.com
71% confidence
AeroLeads found 1 current-domain work email signal for Adam Friedman, Ph.D.. Compare company email patterns before reaching out.
Profile bio
About Adam Friedman, Ph.D.
My career objectives are to develop innovative therapeutics and diagnostics, especially those based on nucleic acids. In addition to creating an R&D team at Atom Bioworks par excellence (who have gotten our DNA STAR SARS-CoV-2 lateral flow assay to pre-EUA, and obtained proof of concept data for the usage of DNA STARs as therapeutics), I have dedicated my career to the amelioration of healthcare problems facing society via multiple modalities, from the development of therapeutics and medical devices, to the improvement of patient outcomes, and the pioneering of administrative initiatives and capabilities. I have extensive commercialization and post-launch expertise in multiple specialty markets, such as Alpha-1 Antitrypsin Deficiency, Hemophilia A and B, Fibrinogen and Acute Hemorrhage, Immune Checkpoint Inhibitors, Sickle Cell Disease, Beta Thalassemia, and others.
Listed skills include Molecular Biology, Research, Biochemistry, Cell Culture, and 46 others.
Current workplace
Adam Friedman, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Atom Bioworks
17 roles
Adam Friedman, Ph.D. work experience
A career timeline built from the work history available for this profile.
Director Of Research & Development
Current
Jan 2024 - Present
Strategic Advisor And Consultant, I.E., Sabbatical Position
- Provide guidance on Atom Bioworks' strategic aims.- As corresponding author, oversee completion of a publication detailing Atom Bioworks' recent therapeutic successes in the use of proprietary nucleic acid scaffolds against Acute Myeloid Leukemia (AML) in vitro and in vivo.
May 2023 - Jan 2024
Director Of Research & Development
- Led the R&D team to FDA pre-EUA for the application of Nucleic acid scaffold (Nas) technology in a SARS-CoV-2 lateral flow assay.- Designed and executed a Nas development program that resulted in the patent conversion of "Multispecific Polynucleotide Nanostructures for Cancer Detection and Therapy":1) Nas scaffolds enhance aptamer affinity (avidity) to.
Jan 2022 - Apr 2023
Director Of Drug Discovery
Developing, reducing to practice, and commercializing Nucleic acid scaffold (Nas) platform technology as diagnostics and theranostics with the mission of detecting and destroying viruses and cancer cells.
Jun 2021 - Jan 2022
Strategic Advisor
Current
Dencoda, Llc
Dencoda, LLC is reducing to practice kinase identification and drugging technologies via the usage of synthetic substrates for application to clinical diagnostics.
Jan 2019 - Present
Senior Consultant
- Directly managed $1.5 million in client accounts. - Subject matter expert (SME)/Franchise leader in the following markets: - Hemophilia (A, B, and bypass agents) - Anticoagulants and anticoagulant reversal - Alpha-1 antitrypsin deficiency - Albumin
Feb 2021 - Jun 2021
Consultant
Oct 2018 - Feb 2021
Associate Consultant
May 2017 - Oct 2018
Adjunct Assistant Professor
- Co-investigator; "Young Innovators Program" Student Science Enrichment Program (SSEP) Burroughs Wellcome Fund. Grant awarded 8/31/2017 and provides funding of $180,000 for 3 years.
- Reviewer; International Journal of STEM Education.
- PI, NC TraCS # 2KR1091802, “In vitro selection of non-binding ssDNA oligos with high serum nuclease resistance”
Jun 2017 - Jun 2020
Invited Proposal Reviewer For The Eshelman Institute For Innovation
Mar 2020 - May 2020
Institute Fellow
- As the first Institute Fellow at the Eshelman Institute for Innovation, I:
- Managed a $70,000 budget for the 2017 year of the Young Innovators Program.
- Pioneered the EII Institute Fellowship.
- Served as a member of the EII Founding and Administrative Teams.
- Served as primary proposal reviewer for 56 EII proposals across three funding rounds.
- Served as a voting member of the funding panel for the April and November 2016 student and postdoc funding rounds.
Oct 2015 - Apr 2017
Orise Post-Baccalaureate Research Fellow
- Designed and implemented an aptamer research program to counter FVIII biosimilar immunogenicity.
- Developed a panel of DNA aptamers specific for Bacillus anthracis Protective Antigen (PA) to detect subtle conformational changes induced by a variety of mutations.
- Trained two high school students as a Howard Hughes Medical Institute (HHMI) Student-Teacher Initiative Program (STIP) Mentor.
Nov 2008 - Jun 2010
Research Scientist Internship
Syntherica Corporation
- Developed antibody-mimetic Synthetides® for targeted therapeutics and environmental diagnostics.
May 2005 - Aug 2005
Research Assistant
I executed a research project aimed at the identification of bacterial species present in bioreactors for the enhanced biological removal of phosphate (EBPR). This involved pioneering a HPLC approach to bacterial species identification based upon heavy isotopes of carbon (C-13) and nitrogen (N-15).
Dec 2004 - May 2005
Research Assistant
I investigated cell surface opacity protein (OPA) variability in Neisseria gonorrhoeae, which is used by this pathogen to evade immunological surveillance.
Mar 2003 - Dec 2004
Research Assistant
I investigated the effect that perturbations of cerebroside levels had on neuronal myelination and associated transcription levels of target genes in murine models.
Mar 2002 - Aug 2002
3 education records
Adam Friedman, Ph.D. education
Doctor Of Philosophy (Ph.D.), Pharmaceutical Sciences
University Of North Carolina At Chapel Hill
Master Of Arts (M.A.), History
East Carolina University
Bachelor Of Science (B.Sc.), Biology, General
University Of North Carolina At Chapel Hill
FAQ
Frequently asked questions about Adam Friedman, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Adam Friedman, Ph.D. work for?
Adam Friedman, Ph.D. works for Atom Bioworks.
What is Adam Friedman, Ph.D.'s role at Atom Bioworks?
Adam Friedman, Ph.D. is listed as Director of Research and Development at Atom Bioworks.
What is Adam Friedman, Ph.D.'s email address?
AeroLeads has found 1 work email signal at @atombioworks.com for Adam Friedman, Ph.D. at Atom Bioworks.
Where is Adam Friedman, Ph.D. based?
Adam Friedman, Ph.D. is based in Chapel Hill, North Carolina, United States while working with Atom Bioworks.
What companies has Adam Friedman, Ph.D. worked for?
Adam Friedman, Ph.D. has worked for Atom Bioworks, Dencoda, Llc, Adivo Associates Llc, Unc Eshelman School Of Pharmacy, and Fda.
How can I contact Adam Friedman, Ph.D.?
You can use AeroLeads to view verified contact signals for Adam Friedman, Ph.D. at Atom Bioworks, including work email, phone, and LinkedIn data when available.
What schools did Adam Friedman, Ph.D. attend?
Adam Friedman, Ph.D. holds Doctor Of Philosophy (Ph.D.), Pharmaceutical Sciences from University Of North Carolina At Chapel Hill.
What skills is Adam Friedman, Ph.D. known for?
Adam Friedman, Ph.D. is listed with skills including Molecular Biology, Research, Biochemistry, Cell Culture, Western Blotting, Data Analysis, Teaching, and Statistics.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial